Page last updated: 2024-08-24

tetraiodothyroacetic acid and Cancer of Mouth

tetraiodothyroacetic acid has been researched along with Cancer of Mouth in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, YR; Chin, YT; Chou, SY; Davis, PJ; Fu, E; Ho, Y; Lee, SY; Lim, YT; Lin, HY; Lin, SJ; Nana, AW; Sh Yang, YC; Shih, YJ; Su, KW; Wang, K; Whang-Peng, J	1

Other Studies

1 other study(ies) available for tetraiodothyroacetic acid and Cancer of Mouth

Article	Year
Nano-diamino-tetrac (NDAT) inhibits PD-L1 expression which is essential for proliferation in oral cancer cells. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2018, Volume: 120 Topics: Antineoplastic Agents; B7-H1 Antigen; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Gene Expression; Gene Knockdown Techniques; Humans; MAP Kinase Signaling System; Mouth Neoplasms; Nanoparticles; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; RNA, Messenger; Thyroxine	2018

Article

Year

Nano-diamino-tetrac (NDAT) inhibits PD-L1 expression which is essential for proliferation in oral cancer cells.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2018, Volume: 120

Topics: Antineoplastic Agents; B7-H1 Antigen; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Gene Expression; Gene Knockdown Techniques; Humans; MAP Kinase Signaling System; Mouth Neoplasms; Nanoparticles; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; RNA, Messenger; Thyroxine

2018